A study in JAMA Internal Medicine found that 17 of 30 medical societies with 10,000 or more members looked at costs when developing treatment guidelines. "Even when they said they looked at costs, they didn't seem to have a clear, consistent or rigorous way to do so," said researcher Dr. Steven Pearson. Nine of 17 used a formal system to assess costs, the study found.

Full Story:

Related Summaries